UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026783 |
|---|---|
| Receipt number | R000030711 |
| Scientific Title | A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasis |
| Date of disclosure of the study information | 2017/05/01 |
| Last modified on | 2023/04/04 09:45:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/03/30 17:49:04 | ||
| 2 | Update | 2018/03/31 09:55:42 | Recruitment status |
|
| 3 | Update | 2022/04/03 12:26:14 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 4 | Update | 2022/04/03 12:26:36 | Recruitment status |
|
| 5 | Update | 2023/04/04 09:45:30 | Recruitment status |
